Hubbard: Thrombosis and Hemostasis Flashcards

1
Q

Hemostasis = process of stopping bleeding at a vascular site by formation of a thrombus.

What is primary hemostasis?

A

Primary hemostasis = Formation of a platelet plug via platelet adhesion and aggregation

  1. Initiation: endothelial injury results in transient vasoconstriction. → exposure of of subendothelial collagen → von Willebrand factor (vWF) binds to exposed collagen. vWF is a glycoprotein made and stored in Weibel-Palade bodies of endothelial cells and α-granules of platelets.
  2. Adhesion (hemostasis):
    - Gp1B-R on platelets bind to vWF => platelets adhere to endothelium.
  3. . Activation: Activated platelets release ADP, thromboxane, Ca2+, and platelet activating factor (PAF), which assist in platelet aggregation, vasoconstriction and degranulation
  4. Aggregation (hemostasis): platelets aggregate w one another via GpIIb/IIIa-receptor and fibrinogen → formation of a white thrombus composed of platelets and fibrin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Hemostasis = process of stopping bleeding at a vascular site by formation of a thrombus.

What is secondary hemostasis?

A

2’ hemostasis = formation of a stable clot via the interaction of the coagulation cascade

  1. Injury to endothelium → (+) of the extrinsic pathway (hemostasis)
  • Tissue factor (factor III), which is present under the endothelium on fibroblasts, binds to and thus activates factor 7 =>
  • Factor 7a and tissue factor form a complex (TF-FVIIa)* that activates factor 10 and factor 9.
  1. (+) of intrinsic pathway (hemostasis), especially through thrombin.
  • Thrombin activates factors 11 and factor 8.
  • Factor 11a activates factor 9.
  • Factors 8a and IXa form a complex* that activates factor 10..
  • This causes a positive feedback loop of factor X and thrombin activation via the intrinsic pathway
  1. The common pathway (hemostasis) of the extrinsic and intrinsic pathways then follows:
    - Factor 10a and factor 5a form a complex* that cleaves prothrombin to thrombin (= factor 2).
    - Thrombin cleaves fibrinogen (factor I) into insoluble fibrin (factor Ia) monomers.
    - Cross links of the fibrin network are stabilized by factor XIIIa → formation of a fibrin network → fibrin closely binds to the platelet plug, forming a stable fibrin clot (secondary or red thrombus)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Which pathway does the prothrombin time (PT) assess; deficiencies of which factors and drugs cause prolongation?

A
  • Monitors extrinsic pathway and warfarin/dicoumaro

- Prolonged in deficiencies of Factors 2, 5, 7, and 10 (vit K) as well as fibrinogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which pathway does the partial thromboplastin time (PTT) assess; deficiencies of which factors and drugs cause prolongation?

A

Monitors the intrinsic system and heparin

  • Prolonged in deficiencies of factors VIII, IX, XI, XII (8, 9, 11, 12)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the NL PT and PTT?

A

NL PT = 10-13 seconds

NL PTT = 25-40 seconds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What does thrombin time (TT) assess?

A

Deficiency/abnormality of fibrinogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is important background information to get in a patient with a clotting/bleeding disorder?

A
  1. Hx (PMH and FHx = never unremarkable; PSH, ALL meds, SocHx (ETOh, recreational meds, occupational), ROS))
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What affects do tonic water have on blood counts?

A

Tonic water (Quinine) = decreases platelet counts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Classes of hemorrhagic disorders

A
  1. Platelet disorders (thrombocytopenia or qualitative platelet disorders)
  2. Factor deficiencies
  3. Endothelial deficiencies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Platelet aggregation studies are important in determining what defects?

A

Qualitative platelet defects: perform when platelets are NL in numbers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the most common cause of abnormal platelet function?

A

Meds (ASA or NSAIDS due to impaired arachidonate metabolism)

  • Very important to make sure pt has not taken these drugs for at least 7 days prior to doing a platelet aggregation study
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the utility of using a 1:1 mixing study in pt with bleeding abnormality?

A
  • Differentiates factor deficiency from presence of a factor inhibitor by mixing the pt plasma w/ normal plasma
  • Factor deficiencies will correct and PTT will correct with mixing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the diagnostic testing utilized for Von Willebrand Disease (wWD)?

A
  • Platelet function analysis (PFA) –> may be normal in mild cases
  • vWF antigen level, vWF activity assay, factor VIII level
  • Platelet aggregation tests are abnormal –> especially to ristocetin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is first-line tx for Von Willebrand Disease (wWD); what else can be given?

A
  • Desmopressin; administered IV or intranasally
  • Can give intermediate-purity factor 8 concentrates, which contain vWF
  • Cryoprecipitate replaces wWF but carries risk of transfusion-transmitted infection!
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the “big 4” drugs associated with thrombocytopenia?

A
  1. Heparin
  2. H2 blockers
  3. ABX (Cephalosporin and penicillins)
  4. Digoxin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is DIC (Disseminated Intravascular Coagulation)?

A

Medical/surgical/obstetrical complication that cause activation of coagulation cascade => escape of thrombin into circulation and resulting formation of thrombi, platelet consumption and exhaustion of all clotting factors. As platelets and clotting factors are depleted, bleeding occurs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Diagnosis of DIC is based on which PT, PTT, thrombine time, D-dimer titer, fibrinogen and platelet level?

A
  • Prolonged PT, PTT and thrombin time.
  • ↑ D-dimer titer
  • ↓ serum fibrinogen and platelet count (thrombocytopenia)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Treatment of DIC

A
  1. Correct underlying disorder (sepsis, bowel obstruction)
  2. If overt thrombosis occurs => heparin.
  3. Supportive care (platelet and factor replacement)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

When would giving heparin be useful for DIC?

A

Only given if overt thrombosis is recognized, unfortunately thrombosis is often masked

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Thrombotic Thrombocytopenic Purpura (TTP) quartad

A
  1. MAHA (microangiopathic hemolytic anemia)
  2. Thrombocytopenia (<50,000)
  3. Fever
  4. Neurological symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Hemolytic Uremic Syndrome (HUS) pentad

A
  1. 4 TTP symptoms

2. + renal failure

22
Q

Histological findings of TTP

A
  1. Microangiopathic anemia - Schistocytes/helmet cells; “Waring blender effect”
  2. Hyaline thrombi, which occlude the capillaries of virtually every organ in body.
23
Q

What is TTP?

A

Disorder that causes thrombosis formation in small vessels, which consumes platelets and leads to thrombocytopenia due to

  • Hereditary mutation of ADAMTS13 (aka “vWF metalloprotease”/ eznyme that cleaves vWF)
  • Acquired via autoAB directed at ADAMTS13.
  • Normally, ADAMTS13 breaks down vWF multimers
  • With disease = large vWF multimers => abnormal platelet adhesion and microthrombi
24
Q

TTP typically occurs in _____

HUS typically occurs in _____.

A

TTP = Females

HUS = children

25
Q

Treatment of TTP

A
  1. Treat causative disorder

2. Plasmapheresis = life saving in 100% of cases. 100% mortality if not treated.

26
Q

What is vonWillebrand diseases?

A

Large group of diseases whose hallmark feature is decreased platelet adhesion to the endothelium due to decreased or absent vWF.

27
Q

Defects in platelet function may be seen in what conditions?

A
  1. Uremia = impaired platelet adhesion
  2. Dysproteinemias = interference with platelet membrane function
  3. AI disorders
28
Q

What is Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu)?

A

AD disorder caused by mutation in TGF-B signaling => defect in gene encoding endolin (CD105), a membrane glycoprotein on endothelial cell that causes dilated tortuous BV with thin walls that bleed easily => serious bleeding.

29
Q

Hereditary hemorrhagic telangiectasia is due to a defect in gene coding what?

A

Endoglin (CD105) a membrane glycoprotein strongly expressed on endothelial cells

30
Q

Clinical features of Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu)?

A
  1. Telangiectasias: appear gradually on skin, mucuous membranes, visceral tissue
  2. Bleeding: epistaxis is most common symptom
31
Q

Course and treatment of Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu)?

A

Benign clinical course: frequent bleeds but death is rare

Surgery and laser photoablation

32
Q

What are the 6 thrombotic disorders

A
  1. Anti-thrombin 3 deficiency
  2. Protein C and S deficiency
  3. Factor 5 Leidin Syndrome
  4. Prothrombin 20210
  5. Antiphospholipid Syndrome
  6. Superficial Venous Thrombosis
33
Q

Which acquired thrombotic disorder is often characterized by recurrent LE thrombophlebitis, DVT/PE, venous insufficiency and chronic leg ulcers?

A

Antithrombin III deficiency => ↓ of a serine protease that inhibits thrombin activation

Thus, ↑ conversion of prothrombin => thrombin (hypercoagulable state)

34
Q

Antithrombin III deficiency is associated with a significantly increased risk of DVT in whom?

A

Pregnant pt’s - due in part to pregnancy causing induced hypercoagulability

35
Q

Diagnosis of antithrombin III deficiency requires what?

A

↓ levels of AT-III in serum (<50% of normal activity)

36
Q

What is the treatment approach for AT-III deficiency, prophylactically and those with DVT; what about pt’s who do not respond?

A
  • Prophylactic anticoagulants for life

- If DVT, give high-dose heparin. If don’t respond => AT-III replacement therapy

37
Q

Protein C and S are dependent on ________.

What do protein C and S do?

A

Vitamin K.

Protein C = inactivates factor 5 and 8

Protein S = cofactor for protein C

38
Q

Which inherited deficiency is the cause of Warfarin-induced skin necrosis in some patients?

A

Protein C deficiency

39
Q

Which therapy is used to decrease the risk of thromboembolic disease in patients with Protein C and S deficiency; why must you be careful?

A
  • Warfarin
  • These proteins are depleted prior to other coagulation factors so there is a temporary increase in coagulation (as they are anticoagulant molecules)!!
  • Must be careful because the most common cause of hypercoagulable state from deficiency of these proteins is the initiation of warfarin therapy!!!
  • Pt needs to be on heparin first, and therapeutically anticoagulated before starting warfarin
40
Q

What is Factor V Leidin mutation?

A

Mutation of Factor 5 Leidin at the binding site for protein C => ↑ hypercoagulable/ thrombolic state

41
Q

Treatment of Factor V Leidin?

A

If no prior episodes, monitor.

Prior episodes: lifelong coagulation

42
Q

What is Prothrombin 20210?

Treatment?

A

G-A mutation resulting in ↑ activity of prothrombin and inability to deactivate prothrombin => ↑↑↑ risk of thrombosis

Treatment = same as Factor V Leidin

43
Q

What is anti-phospholipid syndrome?

A

AI disease that increases the risk of thrombosis as due to AB to phospholipid, such as anti-cardiolipin AB and lupus anticoagulant.

44
Q

What test do patients with APS test (+) for?

A

VDRL or RPR = false (+) because due to anticardiolipin AB.

45
Q

What are some of the common clinical presentations of someone with antiphospholipid syndrome?

A
  1. Thromboembolism
  2. Miscarriage
  3. Pre-mature births
  4. Cerebral ischemia and reccurent stroke (especially in young pt’s)
46
Q

What tests ID lupus anticoagulant in Anti-phospholipid syndrome?

A
  1. Prolonged PTT

2. Prolonged dilute Russell viper venom time (DRVVT) test

47
Q

What are associated features seen in Antiphospholipid syndrome?

A
  1. CT disease (>50% of cases)
  2. Valvular heart disease
  3. Coronary artery disease
48
Q

Diagnosis of APS

A
  1. Prolonged PTT
  2. Lack of correction in 1:1 mixing study (NL plasma + pts plasma)
  3. Neutralize inhibitor wit excess phospholipid to correct ABNLity
49
Q

What is the recommended tx for pt with antiphospholipid syndrome and no hx of thromboembolic disease vs. pt with a hx?

A
  • No hx: Observation: Current recommendation suggests no benefit for anticoagulation;
  • Prior hx: lifelong anticoagulation (warfarin) - don’t base off a single test! Multiple positive tests over a 3-12 month period are required for dx
50
Q

Which drugs can be used for Antiphospholipid Syndrome during pregnancy and pt’s with concurrent SLE?

A
  • Pregnancy: you can anticoagulate with SC heparin

- Hydroxychloroquine: may help ↓ thromboembolism in pt’s with APS and SLE

51
Q

Levels of what should be routinely monitored in pt’s with anticardiolipin antibodies or lupus anticoagulant?

A

Platelet levels since these can cause thrombocytopenia